Nutriband Inc. Profile Avatar - Palmy Investing

Nutriband Inc.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transd…

Biotechnology
US, Orlando [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Nutriband Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of NTRB's Analysis
CIK: 1676047 CUSIP: 67092M208 ISIN: US67092M2089 LEI: - UEI: -
Secondary Listings
NTRB has no secondary listings inside our databases.